GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,666 | -31.1% | 2,814,191 | 0.0% | 0.46% | -4.8% |
Q2 2023 | $15,478 | +27.9% | 2,814,191 | 0.0% | 0.48% | -33.2% |
Q1 2023 | $12,101 | +9.4% | 2,814,191 | 0.0% | 0.72% | +16.5% |
Q4 2022 | $11,060 | -99.9% | 2,814,191 | 0.0% | 0.62% | -3.3% |
Q3 2022 | $14,943,000 | -19.1% | 2,814,191 | 0.0% | 0.64% | -35.3% |
Q2 2022 | $18,461,000 | -10.6% | 2,814,191 | 0.0% | 0.99% | +14.0% |
Q1 2022 | $20,656,000 | +3.7% | 2,814,191 | 0.0% | 0.86% | +59.9% |
Q4 2021 | $19,924,000 | -71.8% | 2,814,191 | 0.0% | 0.54% | -65.7% |
Q3 2021 | $70,552,000 | -6.8% | 2,814,191 | 0.0% | 1.58% | +2.8% |
Q2 2021 | $75,702,000 | -5.5% | 2,814,191 | 0.0% | 1.54% | +8.6% |
Q1 2021 | $80,092,000 | +0.4% | 2,814,191 | 0.0% | 1.42% | -17.4% |
Q4 2020 | $79,782,000 | -8.3% | 2,814,191 | 0.0% | 1.71% | -18.9% |
Q3 2020 | $86,987,000 | +47.2% | 2,814,191 | 0.0% | 2.11% | +27.7% |
Q2 2020 | $59,098,000 | – | 2,814,191 | – | 1.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
Corton Capital Inc. | 15,493 | $102,000 | 0.10% |